Abiopharma

Tentative approval of ANDA #ANDA #211489 for DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE. Decision date: 12/10/2025

Tentative approval of ANDA #ANDA #216757 for MIRABEGRON. Decision date: 12/10/2025

Tentative approval of ANDA #ANDA #219570 for RIFAXIMIN. Decision date: 12/08/2025

Tentative approval of ANDA #ANDA #215547 for CLADRIBINE. Decision date: 12/04/2025

Tentative approval of ANDA #ANDA #220119 for CARBIDOPA,LEVODOPA. Decision date: 12/04/2025

JIUZI HOLDINGS, INC. Announces $4.0 Million Registered Direct Offering

Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights

Bombardier fournira six avions multirôles pour soutenir l’Aviation royale canadienne

Bombardier to Provide Six Multi-role Aircraft to Support the Royal Canadian Air Force

SWE Affinity Groups Celebrate a Stellar 2025

Terra Balcanica Completes 1200 m of Phase III Drilling at Silver-Antimony Targets in Bosnia and Herzegovina

Monument annonce la distribution d’un dividende exceptionnel

Monument gibt Sonderausschüttung bekannt

Orange: Orange announces the signing of a binding agreement with Lorca to acquire their 50% stake in MasOrange

Orange : Orange annonce la signature d’un accord engageant avec Lorca pour acquérir sa participation de 50 % dans MasOrange